Record participation fuels growth at Thailand LAB INTERNATIONAL & Bio Asia Pacific 2023


Thailand LAB INTERNATIONAL, Bio Asia Pacifi c, and FutureCHEM INTERNATIONAL 2023 marked a milestone by hosting the largest number of participants in the last decade. The event welcomed 11,095 attendees from 34 countries, with the top fi ve participant countries being the Philippines, India, China, Singapore, and Malaysia. This diverse attendance, comprising over 45% investors and buyers, led to fruitful business negotiations during the three-day event, held from 6-8 September 2023, at the Bangkok International Trade and Exhibition Center (BITEC).


Organised by VNU Asia Pacifi c in collaboration with the Science and Technology Trade Association (STTA) and the Thailand Center of Excellence for Life Sciences (TCELS), the event showcased the resilience of the laboratory equipment industry, resulting in business negotiations worth over 600 million Baht in the Asia region by year-end.


Mr Anucha Parnpichate, Senior Project Manager of VNU Asia Pacifi c, expressed the organisers’ satisfaction with the event’s success. He highlighted that the substantial attendance fi gures signify Thailand’s ability to overcome economic challenges due to the pandemic, demonstrating readiness to revitalise businesses in the laboratory equipment, life sciences, and chemistry sectors. The event attracted attendees primarily from the chemical, food and beverage, biotechnology, laboratory equipment, and medical device industries. Notably, 70% of pre-registered attendees participated in the show, demonstrating signifi cant interest.


Dr Jittiporn Thammajinda, Chief Executive Offi cer of Thailand Center of Excellence for Life Sciences, emphasised the signifi cance of Bio Asia Pacifi c 2023 as a gateway to the life sciences industry, particularly in healthcare and wellness. The event brought together


contributed to the success of the event.


Introducing ‘Health & Innovation Asia 2024’: A new launch co- located with Thailand LAB INTERNATIONAL 2024, set for 11-13 September 2024, at BITEC Bangkok. This show will focus on health technology, medical and public health innovations, and Thailand’s Digital Health Tech revolution. Mr Igor Jan Palka, Managing Director of VNU Asia Pacifi c, noted the show’s alignment with Thailand’s digital transformation, emphasising its potential to revolutionise healthcare in the region.


The event received positive feedback from participants, with expectations exceeded and opportunities for knowledge exchange and industry connections highlighted.


The show hosted 11,095 attendees from 34 countries.


innovators, technologists, and laboratory experts, with a focus on emerging disease identifi cation and entrepreneurial innovation. Business matching opportunities were a key feature, aiming to facilitate collaborative deals.


The success of the event was a testament to the comprehensive coverage it provided across three co-located shows: Thailand LAB INTERNATIONAL showcased laboratory equipment for scientifi c laboratories, Bio Asia Pacifi c presented research, innovations, and technology in life sciences, biotechnology, and healthcare, and FutureCHEM INTERNATIONAL highlighted chemical innovations for future industries. The event spanned over 14,000 m2, featuring more than 270 exhibitors and over 500 leading brands. Various activities, including social events, guided tours, and seminars,


Elab Informatics appointed as Autoscribe


Informatics LIMS distributor in India


Elab Informatics takes on a new role as the distributor for Autoscribe Informatics’ Matrix Gemini LIMS in India. While Elab Informatics has traditionally excelled in Lab Informatics consulting, this partnership expands its scope to encompass the sale and support of Matrix Gemini LIMS software. With the added capability to configure and provide informatics consulting services, Elab Informatics reinforces its presence in the Indian market.


“Matrix Gemini LIMS provides the ideal foundation for consulting organisations like Elab,” remarked John Boother, Autoscribe Informatics. As India is poised to be one of the world’s fastest- growing economies, the combination of Elab Informatics’ expertise, expansive customer base, and the adaptability of Matrix Gemini LIMS offers a distinctive opportunity for market expansion across the region.


Prashant Gandhi, Founder and Director of Elab Informatics, expressed enthusiasm about adding Matrix Gemini LIMS to their client offerings. “The extraordinary fl exibility of Autoscribe’s software aligns perfectly with Elab Informatics’ mission to help clients realise their laboratory digitisation objectives, drive automation and effi ciency, and fulfi l regulatory requirements spanning various industries. The partnership opens doors for a broader clientele, including manufacturing, pharmaceutical, biotechnology, and environmental sectors. The Low Code Development Platform (LCDP) underlying Matrix Gemini enables swift LIMS confi guration, minimising deployment timelines, support demands, and long-term upgrade costs for clients.”


More information online: ilmt.co/PL/Revb 61481pr@reply-direct.com


The show calendar for 2024/2567 includes the following events:


• Thailand LAB INTERNATIONAL 2024: 11-13 September 2024 at BITEC Bangkok


• Bio Asia Pacifi c 2024: 11-13 September 2024 at BITEC Bangkok


• FutureCHEM INTERNATIONAL 2024: 11-13 September 2024 at BITEC Bangkok


• Health & Innovation Asia 2024: 11-13 September 2024 at BITEC Bangkok


For those interested in securing exhibition booths at these shows, please contact the organisers.


More information online: ilmt.co/PL/9j5N and ilmt.co/PL/k8ZE 61444pr@reply-direct.com


Seeking international distributors for laboratory and diagnostic products


With a rich legacy spanning over fi ve decades, Alpha Laboratories has established itself as a leading provider of top-tier laboratory and diagnostic products worldwide. Recognised for its commitment to quality, innovation, and customer satisfaction, the company has become a trusted brand among healthcare, research, and industrial scientists.


Headquartered in the UK, Alpha Laboratories serves its international customers through valued relationships with overseas distributors. The company is actively seeking new alliances with partners in regions such as France, the Middle East, and other markets, including the USA, India, Singapore, Malaysia, and Indonesia.


John Murphy, Alpha Laboratories’ International Business Manager, extends a warm invitation to potential distributors to collaborate with the company. Distributors can anticipate several benefi ts, including access to an extensive range of renowned laboratory products, global reach through an established presence in over 20 countries, comprehensive training and support, exposure to innovative products and technologies, and growth opportunities within a company with a proven track record of success.


Alpha Laboratories values partnership and collaboration, expressing excitement about welcoming new distributors to help the company reach greater heights. For those passionate about


John Murphy, International Business Manager, Alpha Laboratories.


science, healthcare, and making a difference, this opportunity provides a chance to join a success story.


To learn more about becoming an international distributor for Alpha Laboratories, interested parties can reach out to the company at export@alphalabs.co.uk. Together, they can work towards advancing scientifi c excellence globally.


More information online: ilmt.co/PL/Lo8R 61582pr@reply-direct.com


Acquisition strengthens global CRO capabilities


Resolian, a bioanalytical contract research organisation (CRO) specialising in drug metabolism and pharmacokinetics for small and large molecules, has successfully acquired Denali Medpharma, a leading bioanalytical CRO based in China. This strategic move positions Resolian with bioanalysis laboratory operations in the US, UK, Australia, and China, enabling the initiation of projects on four continents. The transfer of validated methods across labs allows therapeutic trials to extend to virtually any destination without the need to change bioanalytical CROs.


Resolian CEO Patrick Bennett expressed enthusiasm about the acquisition, stating: “The strategic addition of Denali will signifi cantly enhance our capabilities and strengthen our position in the global market. Denali’s founders and core scientists are internationally recognised in pharmaceutical research and development analysis, and we are


particularly excited to incorporate Denali’s expertise in oligo, mRNA, and liposomal analysis into Resolian’s portfolio of services. We look forward to leveraging our growing company’s strengths to continue driving innovation and creating lasting value for our clients and stakeholders.”


Denali CEO Min Meng, Ph.D., shared similar sentiments, stating: “The Denali team is thrilled to join Resolian. Founded by a group of US-trained bioanalytical experts in a state-of-the-art lab facility in China, Denali has consistently provided exceptional service for domestic and international clients. We look forward to continuing this track record and offering even greater capabilities and trial fl exibility as part of Resolian.”


More information online: ilmt.co/PL/Qm3b 61587pr@reply-direct.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44